Friday, February 3, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Purchase DME
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
  • Purchase DME
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Financial Determinants of Health

Jay K Joshi by Jay K Joshi
August 8, 2021
in Financial Markets
0

The greatest ability is availability – a phrase often recited and utilized by motivational speakers and professional athletes, with a generally straightforward meaning.

It does not matter how talented or gifted a person is unless the person utilizes his or her skill set. Similarly, it does not matter how effective a medication is unless a patient takes the medication.

A statement most would consider obvious, but nevertheless remains a major problem in healthcare, as many physicians have long struggled to improve compliance among their patients. For many years the problem was relegated as an unavoidable aspect of patient care, but recently many have tried to address it – with limited benefits.

In recent years, spunky health IT startups promised improved compliance through a clever array of reminders and nudges that showed early results before plateauing out. We quickly realized that there was an upper limit to compliance.

Eventually we realized the issue was more systemic, more fundamental than general reminders. Until we implement broad policy changes in how we care for patients, compliance will not improve, which makes the recent policy changes by the American Diabetes Association (ADA) so newsworthy, despite flying under the pandemic-driven radar.

Early this year the ADA advised that patients who require an additional medication beyond traditional metformin should be prescribed a medication with the lowest cost point. This is a staunch departure from the more clinically stringent recommendations of recent years, in which the ADA parsed various diabetic drugs into different categories of risk, based upon the co-morbidities a patient presents with.

Of late, it seems the ADA prioritizes the financial risk from not affording medications over any clinical risk of complications from taking certain diabetic drugs.

Cost for diabetes medicine has increased dramatically over the past two decades, and an increasing proportion is now passed on to patients and their families. Of note, prices listed are average wholesale prices and National Average Drug Acquisition Costs, separate measures to allow for a comparison of drug prices, but do not account for discounts, rebates, or other price adjustments often involved in prescription sales that affect the actual cost incurred by the patient. Medication costs can be a major source of stress for patients with diabetes and contribute to worse adherence to medications; cost-reducing strategies may improve adherence in some cases.

Rightfully so, as the pandemic has taught us a brutal lesson in patient care – that no matter how sophisticated the clinical data or the care management, the perception of data or care defines how patients internalize it.

This explains why so many patients were noncompliant with masks, despite overwhelming data suggesting they should be worn – especially indoors. The quality of the data was secondary to the perception of the data. And so long as mask wearing remains a political issue, the data will be contextualized within a political framework, which means mask wearing data will forever be examined through a subjective perspective, combining politics with health policy.

A pattern that continued even when the vaccines were introduced, with most of the population hesitant to take the vaccine, relying more on anecdotal evidence from their peers instead of national data to determine whether to take the vaccine.

Vaccine hesitancy defined the initial adoption schedule for vaccines, and remains a large part of the narrative in convincing people to take the vaccine. And explains why people are quick to disregard clinical data when new reports of rare side effects appear afflicting middle aged women who recently received the vaccine.

These are two examples of a broader trend which become an increasing dominant part of healthcare for years if not decades to come. Healthcare will transition away from the clinical rigor of evidence based science, and more into the realm of behavioral economics.

In such a transition, the clinical validity of data will matter less than the public credibility of data. The very concept of subject matter expert will change as more nonclinical public figures will play more and more prominent roles in healthcare – defining public discourse around health policy.

Recently a Twitter battle ensued between Nate Silver, a prominent statistician and editor of a news website, and Dr. Celine Gounder, a physician and cable news media personality. The two argued over the merits of the clinical data around vaccine safety, and whether the data justifies the sudden pause in administering the Johnson & Johnson vaccine.

Lost in the intrigue of two large personalities fighting a digital cat fight is the transition in authority – in the eyes of the public, the statistician is seen as equal to the physician in discerning the medical information and providing insight from that information.

Highlighting a prominent, yet poorly understood trend in healthcare – with clinical data now freely available and the public taking an egalitarian approach to interpreting data, how will trust in healthcare change in the future?

Trust has decentralized away from traditional clinical authorities – most prominently the physician – into a diverse array of thought leaders, online sources, and public references. In many ways this harkens back to the early days of healthcare, in which the doctor treated patients alongside the snake oil salesmen and mother-in-laws.

But in other ways this trend is quite different – largely because of the scale of the internet. With the eminence of online thought leaders, and the inevitable digitization of healthcare, the dissemination of trust into a myriad of decentralized sources will influence the trajectory of future healthcare trends.

Trends that will determine the course of conversation around healthcare data, public trust in physicians, and patient perceptions of healthcare policies.

And when such trends reach policy experts from organizations such as the ADA, they change the clinical guidelines – explaining why the ADA explicitly states that providers should prioritize drug affordability when choosing which medications to prescribe.

In a relatively short amount of time the pandemic has changed the way we perceive healthcare as a whole, influencing how we view healthcare data and decision-making for individual patients.

Eventually the perceptions of healthcare will dominate the data itself, and healthcare will be viewed more through the lens of behavioral economics than as a clinical science.

We should all be ready for this inevitability.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Malicious Prosecution and Fabrication of Evidence

    Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • 2022 Letter to the American Medical Association

    0 shares
    Share 0 Tweet 0
  • 2023 Letter to the American Medical Association

    0 shares
    Share 0 Tweet 0
  • Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do